Compare TGTX & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | SSRM |
|---|---|---|
| Founded | 1993 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.5B |
| IPO Year | 2008 | 1997 |
| Metric | TGTX | SSRM |
|---|---|---|
| Price | $55.60 | $38.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $49.80 | $32.74 |
| AVG Volume (30 Days) | 2.4M | ★ 3.1M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1746.67 | 243.41 |
| EPS | ★ 0.17 | N/A |
| Revenue | $2,785,000.00 | ★ $1,629,637,000.00 |
| Revenue This Year | $49.08 | $56.48 |
| Revenue Next Year | $26.69 | $4.31 |
| P/E Ratio | $326.00 | ★ N/A |
| Revenue Growth | N/A | ★ 63.68 |
| 52 Week Low | $26.76 | $18.12 |
| 52 Week High | $59.30 | $39.43 |
| Indicator | TGTX | SSRM |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 72.22 |
| Support Level | $51.22 | $28.41 |
| Resistance Level | $58.08 | N/A |
| Average True Range (ATR) | 2.24 | 1.21 |
| MACD | 0.74 | 0.79 |
| Stochastic Oscillator | 72.20 | 88.94 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.